Who are Spironolactone and furosemide's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/spironolactone-and-furosemide.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Spironolactone and furosemide — Competitive Intelligence Brief

Spironolactone and furosemide (Spironolactone and furosemide) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combination diuretic (potassium-sparing diuretic + loop diuretic). Area: Cardiovascular.

marketed Combination diuretic (potassium-sparing diuretic + loop diuretic) Aldosterone receptor (spironolactone); Na-K-Cl cotransporter (furosemide) Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Spironolactone and furosemide (Spironolactone and furosemide) — University of Padova. Spironolactone blocks aldosterone to retain potassium while furosemide inhibits sodium reabsorption to promote diuresis, together managing fluid overload and electrolyte balance.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Spironolactone and furosemide TARGET	Spironolactone and furosemide	University of Padova	marketed	Combination diuretic (potassium-sparing diuretic + loop diuretic)	Aldosterone receptor (spironolactone); Na-K-Cl cotransporter (furosemide)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combination diuretic (potassium-sparing diuretic + loop diuretic) class)

University of Padova · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Spironolactone and furosemide — Competitive Intelligence Brief. https://druglandscape.com/ci/spironolactone-and-furosemide. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab